glp 1 and sglt2 GLP-1 receptor agonists inhibitors: a couple at last? Renal outcomes of SGLT2 inhibitors

ACEI: angiotensin-converting enzyme inhibitors

* Clinicians prescribing GLP-1s for #obesity management should focus on and help mitigate these challenges by developing care plans that include thorough #nutritional and #lifestyle #counseling before, during, and after the weight reduction period

Brand-Name Alternatives Brand-name semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are manufactured by pharmaceutical companies and distributed through traditional pharmacies, but their costs often exceed $900$1,400 per month even with insurance coverage

The Long-Term Side Effects of GLP-1 Drugs: What We Know So Far GLP-1 receptor agonistssuch as Ozempic, Wegovy, and Zepbound have skyrocketed in popularity for both type 2 diabetes management and weight loss

& Wan, L